CU Molecular, Cellular, and Developmental Biology
MCDB Home > faculty > FacultyPublications > MartinJMPublications > Early detection of the lytic LMP-1 prote ... ests its presence in the virion
Document Actions

Early detection of the lytic LMP-1 prote ... ests its presence in the virion


Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.

26

The Epstein-Barr virus (EBV)-positive B958 cell line expresses two related membrane proteins encoded by BNLF-1 open reading frames. One protein (LMP-1) has been shown to be essential for the growth transforming properties of EBV. The second protein (the lytic LMP-1) is an amino-terminally truncated form of LMP-1 whose expression is associated with induction of EBV's lytic cycle. We have investigated the expression of full-length and lytic forms of LMP-1 immediately after infection of the EBV-negative, B-lymphoma cell line BJAB. Only the lytic LMP-1 protein is present in BJAB cells early (within minutes following addition of virus) after infection with virus derived from either uninduced or tetradecanoyl phorbol acetate and sodium butyrate-induced B958 cells. Lytic LMP-1 protein levels begin to decline by 48 hr after infection, whereas levels of full-length LMP-1 increase between 24 and 48 hr after infection and then remain constant. The presence of the lytic LMP-1 protein in infected cells is independent of both protein synthesis and virus internalization. We also find the lytic LMP-1 protein in BJAB cells early after infection (within 3 hr of addition of virus) with the HH514 strain of EBV, and HH514 cells treated with tetradecanoyl phorbol acetate and sodium butyrate, express high levels of both the lytic LMP-1 and full-length LMP-1 proteins. The lytic LMP-1 protein is enriched in purified virion preparations, and immunoelectron microscopic analysis indicates that EBV virions can be specifically labeled with anti-LMP-1 antisera. Together, these results are consistent with a model in which the lytic LMP-1 protein is present in the EBV virion and is carried into the B-cell upon infection and suggest a role for this protein in early infection events and/or in EBV's lytic cycle.


Erickson KD, Martin JM

Virology

1997-07-21 00:00

234

1

1-13

Animals,B-Lymphocytes,Butyric Acid,Butyric Acids,Callithrix,Cell Line,Cell Line, Transformed,Cycloheximide,Gene Expression,Herpesvirus 4, Human,Humans,Membrane Proteins,Mitogens,Protein Synthesis Inhibitors,Recombinant Fusion Proteins,Tetradecanoylphorbol Acetate,Tumor Cells, Cultured,Viral Matrix Proteins,Virion,Butyric Acids,EBV-associated membrane antigen, Epstein-Barr virus,Membrane Proteins,Mitogens,Protein Synthesis Inhibitors,Recombinant Fusion Proteins,Viral Matrix Proteins,Butyric Acid,Tetradecanoylphorbol Acetate,Cycloheximide

Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder 80309, USA

Virology

NCI CA 64610

0042-6822

10.1006/viro.1997.8638

S0042-6822(97)98638-4

824

True

9234942

Kimberly Erickson
University of Colorado Contact Us  |   Legal & Trademarks  |  Privacy